Becton Dickinson and Company (BDX) Stock Analysis

Sector: HEALTHCARE - MEDICAL INSTRUMENTS & SUPPLIES

Exchange: NYSE

Key Metrics

• Price: $176.63
• Market Cap: $65.56B
• P/E Ratio: 29.86
• EPS: $6.06
• Dividend Yield: 0.02%
• 52-Week High: $187.35
• 52-Week Low: $126.26

Market Sentiment

Becton Dickinson and Company currently has a Bullish sentiment score of 0.28.

About Becton Dickinson and Company

Becton, Dickinson and Company (BDX) is a leading American multinational medical technology company renowned for its development and production of critical medical devices, instrument systems, and reagents that significantly improve global healthcare outcomes. With a diversified portfolio that supports a wide array of diagnostic and therapeutic procedures, BDX effectively addresses the evolving needs of the healthcare community while providing analytical and consulting services to enhance its ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Becton Dickinson and Company and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is BDX's current dividend yield?

Becton Dickinson and Company (BDX) has a current dividend yield of 0.02%.

Does BDX pay dividends?

Yes, Becton Dickinson and Company pays dividends with a current yield of 0.02%.

What is BDX's P/E ratio?

Becton Dickinson and Company has a price-to-earnings (P/E) ratio of 29.86.

What is BDX's market cap?

Becton Dickinson and Company (BDX) has a market capitalization of $65.56B with a current stock price of $176.63.